Yuvraj

Modern biopharmaceutical facilities are leveraging advanced automation to enhance the production of complex biologics, ensuring real-time quality control and operational efficiency.

Integration of advanced digital technologies into pharmaceutical production is revolutionizing process automation, data integrity, and compliance across the global drug supply chain.

Adopting green hydrogen as a primary energy source in pharmaceutical facilities offers a pathway to deep decarbonization, sustainable process heating, and cleaner manufacturing.

GCCL Co., Ltd. (GCCL) and Medicover Integrated Clinical Services (MICS), a division of Medicover, have entered into a Memorandum of Understanding (MOU) aimed at...

Novartis has started work on a $1.1 billion biomedical research facility in California, adding a major new pillar to its long-term US investment strategy....

Bristol Myers Squibb has entered a global agreement with Evinova to deploy AI-powered clinical development tools across its worldwide pipeline. The Bristol Myers Evinova...

Analysis of the evolving role of functional excipients in modern pharmacology, moving beyond inert fillers to become active participants in drug stability and targeted release.